close icon

Bristol-Myers Stock Pattern Triggers a 37% Surge

Bristol-Myers Squibb and Celgene are expected to merge into a single company before the end of the year. The deal will create the fifth largest pharmaceutical company in the world with sales of approximately $42 billion in 2019.

Bristol-Myers fell sharply after the deal was announced in early-January. In late-April, the stock was still in the doldrums and it seemed like the market does not approve the Celgene deal. But a quick Elliott Wave analysis of BMY’s daily chart revealed a different picture. We shared it with our readers on April 26th.

Bristol-Myers, BMY, to complete Elliott Wave correction

Bristol-Myers was hovering below $46 a share, down from $77 in 2016. However, the structure of this decline looked like an A-B-C flat correction. Waves A and B were simple a-b-c zigzags, while wave C was shaping up as an ending diagonal pattern.

According to the theory, once a correction is over the larger trend resumes. Since Bristol-Myers was clearly in an uptrend prior to July 2016, we thought “it makes sense to expect a bullish reversal” once wave 5 of C is over. As of this writing, the BMY-CELG deal is still pending, but the market seems to be much more optimistic about it.

Bristol-Myers climbs 37% with Celgene deal still pending

Wave 5 fell to $42.48 in July to complete the ending diagonal in wave C. Yesterday, the stock closed at $58.51 for a total gain of 37.7% in less than four months. With the bullish reversal already in place we can confirm Bristol-Myers’ uptrend has resumed. Of course, it won’t move in a straight line, but as long as the $42.48 bottom holds investors can feel confident buying the dips.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Clorox Stock Can Lose 25% if a Recession Hits in 2020

As a consumer products manufacturer Clorox is one of the so-called “defensive” companies, whose sales are generally not dependent on the state of the economy. However, this doesn’t mean Clorox stock cannot fall during a general market decline or a recession. For instance, it lost 57% in the 1999-2000 rout and over 34% during the…

Read More »

Ubiquiti Can Dive in a 50% Elliott Wave Correction

Headquartered in New York, Ubiquiti Inc. is a communication equipment manufacturer with a market cap of ~$13 billion. The stock is up 85% since its late-August low and is now trading in the vicinity of $200 a share. Understandably, such sharp and fast rallies easily attract people’s attention. Extrapolation of the past into the future…

Read More »

Disney Stock Forming a Major Elliott Wave Top

The last time we wrote about Disney stock was on April 17th. The company had just announced its own streaming service, sending the price sharply higher to over $130 a share. The interesting part was not the surge itself, but the fact that the Elliott Wave principle managed to prepare us for it a year…

Read More »

Home Capital: Third Wave Lifts Stock 140% in 2019

Home Capital Group is up 17.4% in Toronto today following the company’s third quarter financial report. The mortgage lender beat analysts’ earnings expectations and delivered improvements in other areas, too. In total, HCG is up ~140% in 2019. But things didn’t look so rosy at the beginning of the year. The stock was hovering in…

Read More »

Walgreens: Did the Market Foresee that KKR Offer?

Anyone who’s been in Elliott Wave analysis long enough has noticed how often some external factor “makes the price move” in the direction the analysis had identified much earlier. We’ve seen it happening in crypto, we’ve seen in happening in stock indices. Now, it happened with Walgreens stock. Walgreens jumped on November 5th after CNBC…

Read More »

SERV Stock Gave a Warning Before Crashing 40%

The last three weeks have been tough on ServiceMaster shareholders. SERV stock was hovering around $56 a share as October went into its final third. But when the company announced its preliminary Q3 results on October 22nd, all hell broke loose. Apparently, Wall Street didn’t like what it saw, which resulted in a swift and…

Read More »

Expedia Disappointed. Elliott Wave Analysis Did Not

Expedia stock is down 25% today after the company’s Q3 results missed expectations. GAAP EPS fell 57 cents short of analysts’ estimates. The revenue figure was anticipated to be $10 million higher than reported, as well. On top of that, Expedia cut its full-year guidance which annoyed Wall Street even more. That is the official…

Read More »

More analyses